Food News and Research

RSS

GTSI named value-added reseller of the Intel Health Guide RPM solution

GTSI Corp. an enterprise technology solutions and services provider was recently named a value-added reseller to deliver the Intel® Health Guide, a comprehensive, next-generation remote patient monitoring (RPM) solution that combines an in-home patient device, the Intel Health Guide PHS6000, with the Intel® Care Management Suite, an online interface that allows clinicians to monitor patients and remotely manage care.

3 Dec 2009

Endo Pharmaceuticals receives FDA complete response letter for AVEED NDA

Endo Pharmaceuticals today announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for its extended-duration testosterone undecanoate injection, AVEED(TM), for men diagnosed with low testosterone.

3 Dec 2009

Avisio forms new subsidiary to market its virus detecting nano sensory technology

Avisio, Inc. announced today that it has formed a majority-owned subsidiary to market and commercialize Instant Detect, the company's new nano sensory technology that instantly detects biological viruses. The new company, Diagnostic Nano Applications (DNA), will be headquartered in Riverside, California.

3 Dec 2009

Ingredia Nutritionals to distribute Nutrition 21's Chromax and Diachrome ingredients in the EU

Nutrition 21, Inc., the developer and marketer of nutritional ingredients for the dietary supplement, and functional food and beverage markets announced today that chromium picolinate has been added to the approved list of ingredients allowed to be used in food supplements in the European Union (EU).

3 Dec 2009

Nonanesthesiologist-administered propofol for GI procedures safe

The worldwide safety experience of endoscopist-administered propofol sedation now exceeds 600,000 patients. The low rate of serious adverse events underscores the safety of nonanesthesiologist-administered propofol (NAAP) for gastrointestinal (GI) procedures, provided that it is administered by a team of individuals who have received training specific to the administration of propofol according to the "Position statement: nonanesthesiologist administration of propofol for GI endoscopy" issued by the four major gastroenterology and hepatology societies.

3 Dec 2009

Financial aspects of cancer treatment reduces compliance

New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient’s battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients’ compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.

3 Dec 2009

China's SFDA initiates quality investigation of Simcere Pharmaceutical Group subsidiary's rabies vaccine

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").

3 Dec 2009

Body needs fasting periods to stay healthy

A body that is provided with food too often gets caught up in the maelstrom of a lack of exercise, obesity and ultimately diabetes. The trigger is a molecular switch that is controlled by insulin, a new study by scientists from ETH Zurich has revealed.

3 Dec 2009

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company’s novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.

3 Dec 2009

Sodexo launches 'Better Tomorrow Plan' to meet the challenges of community and environmental practices

Sodexo (PARIS:SW) (OTCBB:SDXAY), world leader in Quality of Life solutions, announced today the creation of the "Better Tomorrow Plan," designed to better respond to the challenges of proper Nutrition, Health and Wellness, Local communities and Environment.

3 Dec 2009

Videos can help overcome communication barriers and influence patients' choices for medical care

Patients with terminal brain cancer who watched a brief video illustrating options for end-of-life care were significantly more likely to indicate a preference for comfort measures only than were patients who listened to a verbal description of treatment choices.

3 Dec 2009

AACR offers a compendium of best research practices to aid the FDA in regulating tobacco

When President Barack Obama signed the Family Smoking Prevention and Control Act in June, he ushered in a new era of tobacco policy that empowers the Food and Drug Administration to regulate one of the world's most controversial and deadly consumer products.

3 Dec 2009

Roche to provide the RealTime ready Influenza A/H1N1 Detection Set to CLIA high-complexity labs under EUA

The Roche assay for the 2009 H1N1 influenza virus detects RNA from the 2009 H1N1 Influenza A virus and provides a rapid means of identification of patients infected with this virus. In order to ensure continued specificity and sensitivity of the Roche's Influenza A/H1N1 assay, Roche performs sequence comparisons with all available 2009 H1N1 Influenza Virus sequences on a regular basis.

3 Dec 2009

Study sheds light on gender differences in shopping experiences and behaviors

Daniel Kruger, research faculty at the University of Michigan School of Public Health, says it's perfectly natural that men often can't distinguish a sage sock from a beige sock or that sometimes women can't tell if the shoe department is due north or west from the escalator.

3 Dec 2009

Breast Cancer Fund: Congress must enforce BPA ban in food and beverage containers

In the wake of the first evidence that American babies are born contaminated with a plastics chemical linked to birth defects and breast cancer, Congress must act immediately to protect infants and mothers.

3 Dec 2009

Despite declining smoking rates, U.S. obesity rates continue to rise

If obesity trends continue, the negative effect on the health of the U.S. population will overtake the benefits gained from declining smoking rates, according to a study by U-M and Harvard researchers published today in the New England Journal of Medicine.

3 Dec 2009

Generational and aging influences may have a major impact on future of eating

Each generation will make a distinctive mark on how and what Americans will be eating in 10 years, according to The NPD Group, a leading market research company. In its A Look into The Future of Eating report, NPD’s food industry market research finds that eating patterns over the next decade will be influenced by the behaviors that occur with aging, and the differences in preferences from one generation to another.

3 Dec 2009

Lunasin may have important health benefits, two new studies report

Two new University of Illinois studies report that lunasin, a soy peptide often discarded in the waste streams of soy-processing plants, may have important health benefits that include fighting leukemia and blocking the inflammation that accompanies such chronic health conditions as diabetes, heart disease, and stroke.

3 Dec 2009

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

AstraZeneca and Targacept, Inc. today announced a collaboration and license agreement for the global development and commercialization of TC-5214, Targacept’s late-stage investigational product for major depressive disorder (MDD).

3 Dec 2009

European Phase III clinical trial of budesonide MMX completes patient enrollment

Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.

3 Dec 2009

Food News and Research

GTSI named value-added reseller of the Intel Health Guide RPM solution

Endo Pharmaceuticals receives FDA complete response letter for AVEED NDA

Avisio forms new subsidiary to market its virus detecting nano sensory technology

Ingredia Nutritionals to distribute Nutrition 21's Chromax and Diachrome ingredients in the EU

Nonanesthesiologist-administered propofol for GI procedures safe

Financial aspects of cancer treatment reduces compliance

China's SFDA initiates quality investigation of Simcere Pharmaceutical Group subsidiary's rabies vaccine

Body needs fasting periods to stay healthy

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

Sodexo launches 'Better Tomorrow Plan' to meet the challenges of community and environmental practices

Videos can help overcome communication barriers and influence patients' choices for medical care

AACR offers a compendium of best research practices to aid the FDA in regulating tobacco

Roche to provide the RealTime ready Influenza A/H1N1 Detection Set to CLIA high-complexity labs under EUA

Study sheds light on gender differences in shopping experiences and behaviors

Breast Cancer Fund: Congress must enforce BPA ban in food and beverage containers

Despite declining smoking rates, U.S. obesity rates continue to rise

Generational and aging influences may have a major impact on future of eating

Lunasin may have important health benefits, two new studies report

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

European Phase III clinical trial of budesonide MMX completes patient enrollment

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News